Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...

Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

Strategies to optimize structures A detailed knowledge of antibody structure and activity now ... proof-of-concept of the clinical efficacy of new protein scaffolds with different pharmacological ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing ...

Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing ...